STOCK TITAN

FMR LLC discloses 7.6% Veradermics Inc. (MANE) ownership in Schedule 13G

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

FMR LLC and associated person Abigail P. Johnson report a significant passive ownership position in Veradermics Inc. common stock. They disclose beneficial ownership of 3,193,181 shares of common stock, representing 7.6 % of the outstanding class as of June 30, 2026.

FMR LLC reports sole voting power over 3,193,077 shares and sole dispositive power over 3,193,181 shares, with no shared voting or dispositive power. Abigail P. Johnson is reported as having sole dispositive power over 3,193,181 shares and no voting power, reflecting her control position through FMR LLC and its subsidiaries.

The filing notes that one or more other persons have the right to receive dividends or sale proceeds related to these shares, but no such person holds an interest exceeding 5 % of Veradermics Inc. common stock. The securities are held through subsidiaries identified in an accompanying Exhibit 99.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 3,193,181 shares Common stock of Veradermics Inc. beneficially owned by FMR LLC and Abigail P. Johnson
Percent of class 7.6 % Portion of Veradermics Inc. common stock class reported as beneficially owned
Sole voting power 3,193,077 shares Shares of Veradermics Inc. over which FMR LLC has sole voting power
Sole dispositive power (FMR LLC) 3,193,181 shares Shares of Veradermics Inc. over which FMR LLC has sole dispositive power
Sole dispositive power (Abigail P. Johnson) 3,193,181 shares Shares of Veradermics Inc. over which Abigail P. Johnson has sole dispositive power
CUSIP 922967104 CUSIP for Veradermics Inc. common stock reported in the Schedule 13G
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 3193181.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power financial
"5 | Sole Voting Power 3,193,077.00 6 | Shared Voting Power 0.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power financial
"7 | Sole Dispositive Power 3,193,181.00 8 | Shared Dispositive Power 0.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Schedule 13G regulatory
"Please see Exhibit 99 for 13d-1(k) (1) agreement."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
percent of class financial
"(b) | Percent of class: 7.6 %"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What ownership stake in MANE (Veradermics Inc.) does FMR LLC report?

FMR LLC reports beneficial ownership of 3,193,181 shares of Veradermics Inc. common stock, representing 7.6 % of the outstanding class as of June 30, 2026, according to the Schedule 13G filing.

How much voting power over MANE shares does FMR LLC hold?

FMR LLC reports sole voting power over 3,193,077 shares of Veradermics Inc. and no shared voting power. This indicates that voting decisions for these shares are controlled solely by FMR LLC or its subsidiaries.

What role does Abigail P. Johnson have in the MANE ownership reported?

Abigail P. Johnson is reported as beneficial owner with sole dispositive power over 3,193,181 shares of Veradermics Inc., but no voting power. Her authority is exercised through FMR LLC and its direct and indirect subsidiaries.

Does any other person hold more than 5% of MANE through FMR LLC’s holdings?

The filing states that one or more other persons may receive dividends or sale proceeds from these MANE shares, but no single person’s interest exceeds 5 % of Veradermics Inc.’s total outstanding common stock.

What class of MANE securities is covered by this Schedule 13G?

The Schedule 13G covers common stock of Veradermics Inc., identified by CUSIP 922967104. All reported ownership figures, including the 3,193,181 shares and 7.6 % stake, relate to this class.

Where are the principal offices of Veradermics Inc. and FMR LLC?

Veradermics Inc. lists its principal executive offices at 470 James Street, New Haven, CT 06513. FMR LLC’s principal business office is 245 Summer Street, Boston, Massachusetts 02210, as disclosed in the Schedule 13G.





922967104

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



FMR LLC
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:08/05/2026
Abigail P. Johnson
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
Date:08/05/2026

Comments accompanying signature: * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.